Several legislators were joined by cancer advocates and even a cancer survivor for a press conference introducing a bill that would require insurance companies to provide equal payments to patients for both oral and intravenous treatments.
House Bill 265, The Delaware Cancer Treatment Access Act, would require insurers to provide the same reimbursements for patients who use either IV or oral chemotherapy. Cancer advocates say under prescription plans, the co-pays are much higher than the IV infusions, which under a health insurance plan usually costs around $20 to $30 an office visit. Rep. Ruth Briggs King is one of three Representatives and two Senators who are sponsoring the bill, which was written with help from a pair of oncologists.
No comments:
Post a Comment